Left Menu
Development News Edition

British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine

Reuters | Updated: 03-02-2020 06:19 IST | Created: 03-02-2020 05:32 IST
British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine
Representative image Image Credit: ANI

British drugmaker GlaxoSmithKline Plc is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) to contribute towards the effort of developing a vaccine for the coronavirus outbreak, GSK and CEPI said on Monday. GSK will make its "adjuvant platform technology" available for developing a vaccine against the 2019-nCoV virus, according to the statement.

The use of adjuvant allows for production of more vaccine doses and hence would increase availability to more people. GSK will engage with entities funded by the CEPI with the first of these agreements having been signed between the British drugmaker and Australia's University of Queensland, the statement added.

The fast-moving flu-like virus has killed more than 300 people in China, spread to more than two dozen countries and caused the world's second-largest economy to be hit by travel curbs and business shut-downs. There is currently no vaccine available against the coronavirus but several organizations including CEPI, a public-private body based in Norway, are working at developing one.

France's Pasteur Institute Foundation said on Friday it had set up a task force aimed at developing a vaccine against the virus in 20 months while Germany's research minister said she expected a vaccine to be developed within "a few months".

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Download The Devdiscourse News App for Latest News.



Rising temperatures in India seem to counter the spread of COVID 19 infections

Scary predictions on the rate of spread of COVID 19 infections in India are floating in media. But the data on the spread of infections coming so far point to a contrary trajectory putting a question mark on such predictions. Explanations o...

Sanitation post-COVID 19: Tissue paper not in fashion, learn to wash

Tissue paper has failed COVID 19 test. The modern understanding of sanitation is passing through a stage of transformation. Those who used to feel proud of using tissue paper have been compelled to wash frequently their hands with soap. In ...

Globalization post-coronavirus to get a hit, self-sufficiency paradigm to rule

The massive scale of coronavirus outbreak, accompanied by uncertainty and fear, could lead to new behaviors and beliefs in the 21st-century population that is empowered with the internet....

Ayurveda for COVID 19: Professionals owe the responsibility to protect it from quacks and fake news

Indian Ayurveda professionals are lagging behind their foreign counterparts in handling quacks and protecting credentials of the Ayurveda at the time of COVID 19 pandemic. The professionals of Ayurveda cannot abjure the responsibility to co...


Latest News

Europe's hospitals running out of ICU meds for COVID-19

Nine leading European university hospitals are warning they will run out of essential medicines needed for COVID-19 patients in intensive care in less than two weeks as they are increasingly crushed by the pandemic. The European University ...

US STOCKS SNAPSHOT-Futures pare gains as U.S. weekly jobless claims top 6 million

U.S. stocks index futures gave up early gains on Thursday after the number of Americans filing claims for unemployment benefits topped a whopping 6 million as more jurisdictions enforced stay-at-home measures to curb the coronavirus.At 840 ...

Haryana CM announces to launch telemedicine services, bats for more COVID-19 testing facilities

Haryana Chief Minister Manohar Lal Khattar on Thursday announced to roll out telemedicine services besides stressing the need to augment testing facilities during a videoconference over the coronavirus outbreak with Prime Minister Narendra ...

What about us? Russia's coronavirus supplies to United States spark criticism at home

A Russian medical equipment delivery to the United States to help fight the coronavirus drew anger from critics of the Kremlin on Thursday who pointed out that Russia was itself experiencing severe shortages of such items. A Russian militar...

Give Feedback